サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1781438

コンパニオンアニマル用医薬品の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

Global Companion Animal Pharmaceuticals Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 183 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.67円
コンパニオンアニマル用医薬品の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測
出版日: 2025年08月01日
発行: Value Market Research
ページ情報: 英文 183 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

コンパニオンアニマル用医薬品の世界市場規模は、2024年の188億1,000万米ドルから2033年には303億5,000万米ドルに成長し、2026年から2033年の予測期間中に5.46％の堅調な年間平均成長率（CAGR）を示すと予測されます。

コンパニオンアニマル用医薬品市場は、ペットの飼育が世界的に増加し続け、ペットの健康と福祉への注目が高まるにつれて、大きく成長する見込みです。ペットの飼い主が動物を家族の一員とみなすようになっているため、ワクチン、抗寄生虫薬、疼痛管理ソリューションを含む動物用医薬品の需要が急増しています。この動向は、予防ヘルスケアに対する意識の高まりや、定期的な動物病院での検診の重要性によってさらに拍車がかかっています。市場が発展するにつれて、製薬会社はコンパニオンアニマル特有の健康ニーズに対応する革新的な治療法を生み出すための研究開発に投資し、将来の成長への力強い軌道を確実なものにしていくと思われます。

さらに、獣医学と技術の進歩がコンパニオンアニマル用医薬品の能力を高めています。標的治療薬と生物製剤の開発は、治療状況に革命をもたらし、ペットの様々な健康状態を管理するためのより効果的で安全な選択肢を提供しています。さらに、獣医療における遠隔医療の台頭は医薬品へのアクセスを容易にし、ペットの飼い主が遠隔で獣医師と相談し、必要な医薬品をより便利に入手することを可能にしています。市場がこのような技術的進歩に適応し続けるにつれて、技術革新とアクセシビリティへの注目がコンパニオンアニマル用医薬品分野の成長を促進するでしょう。

さらに、ペットのウェルネスと予防医療への重点の高まりは、コンパニオンアニマル用医薬品市場に影響を与えており、ペットの飼い主は全体的な健康と長寿を促進する製品を求めているからです。関節の健康、皮膚や被毛の状態、消化器の健康をサポートするように設計された栄養補助食品やサプリメントは、消費者の間で人気を集めています。市場が発展するにつれ、医薬品とウェルネス製品の統合は、コンパニオンアニマルのホリスティックな健康ニーズに応えるメーカーに新たな機会をもたらすと思われます。技術革新、アクセシビリティ、消費者教育に重点を置くことで、コンパニオンアニマル用医薬品市場の将来は有望であり、より充実したペットケアソリューションへの道が開かれるでしょう。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察をお客様に提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます：

市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクション。

市場力学：市場成長に影響を与える主な促進要因・抑制要因・機会・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場企業の包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測します。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開発と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 コンパニオンアニマル用医薬品-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 コンパニオンアニマル用医薬品の世界市場分析：種類別

  • 概要：種類別
  • 種類別過去・予測データ分析
  • 馬
  • 猫
  • 犬
  • コンパニオンアニマル

第6章 コンパニオンアニマル用医薬品の世界市場分析：適応症別

  • 概要：適応症別
  • 適応症別過去・予測データ分析
  • 皮膚疾患
  • 感染症
  • 行動障害
  • 整形外科疾患

第7章 コンパニオンアニマル用医薬品の世界市場分析：流通チャネル別

  • 概要：流通チャネル別
  • 流通チャネル別過去・予測データ分析
  • 病院薬局
  • eコマース
  • 小売

第8章 コンパニオンアニマル用医薬品の世界市場分析：製品別

  • 概要：製品別
  • 製品別過去・予測データ分析
  • ワクチン
  • 生物製剤

第9章 コンパニオンアニマル用医薬品の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、歴史的推移および予測
    • 北米：セグメント別
    • 北米国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績と予測
    • アジア太平洋地域：セグメント別
    • アジア太平洋地域国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東アフリカ売上分析
    • 概要、実績と予測
    • 中東アフリカ：セグメント別
    • 中東アフリカ国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第10章 コンパニオンアニマル用医薬品企業の競合情勢

  • コンパニオンアニマル用医薬品市場の競合
  • パートナーシップ／提携／合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Merck Animal Health
  • Zoetis Inc.
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health
  • Neogen Corporation
  • Boehringer Ingelheim Animal Health
  • Aratana Therapeutics
  • Bayer Animal Health
  • Norbrook Laboratories
  • Virbac
  • Kindred Biosciences
  • Ceva Sante Animale
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Form (USD MN)
  • Horses Market Sales By Geography (USD MN)
  • Cats Market Sales By Geography (USD MN)
  • Dogs Market Sales By Geography (USD MN)
  • Companion Animals Market Sales By Geography (USD MN)
  • Analysis By Indication (USD MN)
  • Dermatologic Diseases Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Behavioral Diseases Market Sales By Geography (USD MN)
  • Orthopedic Diseases Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacy Market Sales By Geography (USD MN)
  • E-Commerce Market Sales By Geography (USD MN)
  • Retail Market Sales By Geography (USD MN)
  • Analysis By Product (USD MN)
  • Vaccine Market Sales By Geography (USD MN)
  • Biologics Market Sales By Geography (USD MN)
  • Global Companion Animal Pharmaceuticals Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Companion Animal Pharmaceuticals Report
  • Market Research Process
  • Market Research Methodology
  • Global Companion Animal Pharmaceuticals Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Form
  • Market Attractiveness Analysis By Indication
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Form (USD MN)
  • Horses Market Sales By Geography (USD MN)
  • Cats Market Sales By Geography (USD MN)
  • Dogs Market Sales By Geography (USD MN)
  • Companion Animals Market Sales By Geography (USD MN)
  • Global Market Analysis By Indication (USD MN)
  • Dermatologic Diseases Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Behavioral Diseases Market Sales By Geography (USD MN)
  • Orthopedic Diseases Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacy Market Sales By Geography (USD MN)
  • E-Commerce Market Sales By Geography (USD MN)
  • Retail Market Sales By Geography (USD MN)
  • Global Market Analysis By Product (USD MN)
  • Vaccine Market Sales By Geography (USD MN)
  • Biologics Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112114742

Global Companion Animal Pharmaceuticals Market size is anticipated to grow from USD 18.81 Billion in 2024 to USD 30.35 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 5.46% during the forecast period of 2026 to 2033.

The companion animal pharmaceuticals market is poised for significant growth as pet ownership continues to rise globally, leading to an increased focus on the health and well-being of pets. As pet owners increasingly view their animals as family members, the demand for veterinary medicines, including vaccines, anti-parasitics, and pain management solutions, is surging. This trend is further fueled by the growing awareness of preventive healthcare and the importance of regular veterinary check-ups. As the market evolves, pharmaceutical companies are likely to invest in research and development to create innovative treatments that address the specific health needs of companion animals, ensuring a robust trajectory for future growth.

Moreover, advancements in veterinary medicine and technology are enhancing the capabilities of companion animal pharmaceuticals. The development of targeted therapies and biologics is revolutionizing the treatment landscape, offering more effective and safer options for managing various health conditions in pets. Additionally, the rise of telemedicine in veterinary care is facilitating access to pharmaceuticals, allowing pet owners to consult with veterinarians remotely and obtain necessary medications more conveniently. As the market continues to adapt to these technological advancements, the focus on innovation and accessibility will drive growth in the companion animal pharmaceuticals sector.

Furthermore, the increasing emphasis on pet wellness and preventive care is influencing the companion animal pharmaceuticals market, as pet owners seek products that promote overall health and longevity. Nutraceuticals and supplements designed to support joint health, skin and coat condition, and digestive health are gaining popularity among consumers. As the market evolves, the integration of pharmaceuticals with wellness products will create new opportunities for manufacturers to cater to the holistic health needs of companion animals. With a focus on innovation, accessibility, and consumer education, the future of the companion animal pharmaceuticals market looks promising, paving the way for enhanced pet care solutions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Animal Type

  • Dogs
  • Cats
  • Horses

By Route of Administration

  • Oral
  • Injectable
  • Topical

By Product

  • Drugs
  • Vaccines
  • Medicated Feed Additives

By Drug Class

  • Antibiotics
  • Anti-inflammatory
  • Heart Worm Drugs
  • Parasiticides
  • Nutritional Drugs
  • Behavioral Drugs
  • Vaccines
  • Others

By Distribution Channel

  • Veterinary Hospitals
  • Clinics
  • COMPANIES PROFILED
  • Boehringer Ingelheim International GmbH
  • Ceva
  • Balchem Corp.
  • Chanelle Pharma
  • Dechra Pharmaceuticals Limited
  • Elanco or its affiliates
  • ECO - Animal Health Ltd.
  • Enovis Corporation
  • Invetx
  • Merck & Co. Inc.
  • MP AGRO CO.
  • LTD.
  • Neogen Corporation
  • Norbrook
  • Orion Corporation
  • Sumitomo Corporation
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. COMPANION ANIMAL PHARMACEUTICALS – INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Form
    • 3.7.2 Market Attractiveness Analysis By Indication
    • 3.7.3 Market Attractiveness Analysis By Distribution Channel
    • 3.7.4 Market Attractiveness Analysis By Product
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET ANALYSIS BY FORM

  • 5.1. Overview By Form
  • 5.2. Historical and Forecast Data Analysis By Form
  • 5.3. Horses Historic and Forecast Sales By Regions
  • 5.4. Cats Historic and Forecast Sales By Regions
  • 5.5. Dogs Historic and Forecast Sales By Regions
  • 5.6. Companion Animals Historic and Forecast Sales By Regions

6. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET ANALYSIS BY INDICATION

  • 6.1. Overview By Indication
  • 6.2. Historical and Forecast Data Analysis By Indication
  • 6.3. Dermatologic Diseases Historic and Forecast Sales By Regions
  • 6.4. Infectious Diseases Historic and Forecast Sales By Regions
  • 6.5. Behavioral Diseases Historic and Forecast Sales By Regions
  • 6.6. Orthopedic Diseases Historic and Forecast Sales By Regions

7. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 7.1. Overview By Distribution Channel
  • 7.2. Historical and Forecast Data Analysis By Distribution Channel
  • 7.3. Hospital Pharmacy Historic and Forecast Sales By Regions
  • 7.4. E-Commerce Historic and Forecast Sales By Regions
  • 7.5. Retail Historic and Forecast Sales By Regions

8. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET ANALYSIS BY PRODUCT

  • 8.1. Overview By Product
  • 8.2. Historical and Forecast Data Analysis By Product
  • 8.3. Vaccine Historic and Forecast Sales By Regions
  • 8.4. Biologics Historic and Forecast Sales By Regions

9. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East Africa By Segment Sales Analysis
    • 9.7.3 Middle East Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE COMPANION ANIMAL PHARMACEUTICALS COMPANIES

  • 10.1. Companion Animal Pharmaceuticals Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF COMPANION ANIMAL PHARMACEUTICALS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Merck Animal Health
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Zoetis Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Dechra Pharmaceuticals PLC
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Elanco Animal Health
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Neogen Corporation
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Boehringer Ingelheim Animal Health
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Aratana Therapeutics
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Bayer Animal Health
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Norbrook Laboratories
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Virbac
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Kindred Biosciences
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Ceva Sante Animale
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies